| Serial Number | 97243682 |
| Word Mark | HIPRA |
| Filing Date | Friday, January 28, 2022 |
| Status | 748 - STATEMENT OF USE - TO EXAMINER |
| Status Date | Friday, October 3, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, October 24, 2023 |
| Description of Mark | The mark consists of the stylized wording "HIPRA" in white inside a blue rectangle. |
| Goods and Services | Pharmaceutical products, namely, biological vaccines for human and veterinary use; biological preparations for medical and veterinary use, namely, veterinary vaccines; veterinary preparations for the treatment of intestinal bacteria; anti- infective products for veterinary use; insecticidal washing products for veterinary use; veterinary products and substances, namely, vaccines for prevention of animal illness; biological reagents for veterinary use; diagnostic reagents for veterinary use; reagents for clinical analyses for veterinary purposes; reagents for microbiological analyses for veterinary purposes; reagents for chemical analyses for veterinary purposes; reagents for veterinary diagnosis; reagents for diagnostic tests for veterinary purposes; reagents for use with analyzers for veterinary purposes; reagents for use in analyses for veterinary use, reagents for in-vitro laboratory use for veterinary purposes; reagents for use in analysis for veterinary use, reagents for in-vitro laboratory use for veterinary purposes; chemical reagents for medical or veterinary purposes; chemical reagents for veterinary use; reagents and media for medical and veterinary diagnostic purposes; nucleic acid sequences for medical and veterinary use; dietary supplements for veterinary use; veterinary substances and preparations, namely, vaccines for prevention of animal illness; oral vaccine preparations; vaccine preparations for human use; vaccines; influenza vaccines; vaccines against pneumococcal infections; vaccines for horses; vaccines for cattle; vaccines for infections in animal hooves; vaccines for human use; veterinary vaccines; viral vaccines |
| Indication of Colors claimed | The color(s) white and blue is/are claimed as a feature of the mark. |
| Goods and Services | Scientific and technological services, as well as associated research and design services, namely, scientific research, analysis and testing in the field of pharmaceutical, veterinary, and sanitary products and material, surgical, medical, and veterinary apparatus, devices, and instruments; industrial analysis and research services in the field of pharmaceutical, veterinary, and sanitary products and material, surgical, medical, and veterinary apparatus, devices, and instruments, as well as of computer software related to the biomedical and pharmaceutical sector, and industrial design services; quality control services for others in the field of pharmaceutical, veterinary, and sanitary products and material, surgical, medical, and veterinary apparatus, devices and instruments; design and development of computer hardware and software; research and development of vaccines; veterinary laboratory services; services for assessing the effectiveness of veterinary medicines; design of laboratory animal housing systems; biotechnology research for determining the neuronal survival of molecules in animal models; research regarding farm animal breeding; genetic tests of laboratory animals for research; consultancy in pharmaceutical research; consultancy related to pharmacology; consultancy related to pharmacogenetics research; consultancy related to pharmaceutical research and development; development of pharmaceutical preparations and medicines; development of pharmaceutical products; clinical studies for pharmaceutical products; evaluation of pharmaceutical products; scientific and medical research information regarding pharmaceutical products and clinical trials; inspection of pharmaceutical products; scientific research in the field of pharmaceuticals; research in the field of pharmacogenetics; research regarding pharmaceutical products; research and development in the field of pharmaceuticals and biotechnology; pharmaceutical research and development; research and development for the pharmaceutical industry; conducting clinical trials for pharmaceutical products; conducting early evaluations in relation to new pharmaceutical products; pharmaceutical drug development services; drug discovery services; pharmaceutical product efficacy assessment services; medical and pharmacological research services; pharmaceutical research and development services; information technology services for the pharmaceutical and health-care industries, namely, information technology consulting services; provision of information regarding results of clinical trials relating to pharmaceutical products; electronic storage of medical records; design and development of medical diagnostic apparatus; scientific research for medical purposes; medical laboratories; programming for computers in the medical field; information and data services regarding medical and veterinary research and development; services of a medical laboratory; non-medical ultrasound imaging services; provision of scientific information regarding medical disorders and their treatment; research and development of vaccines and medicines; biological research and analysis; development of computer software in the pharmaceutical, medical, veterinary, sanitary and diagnostic field; clinical research in the field of veterinary preparations, biotherapeutic medicines, and antibodies; blood testing services for scientific research; scientific analysis services relating to the assessment of bacteria content in liquids |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, February 1, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | Monday, November 30, 2020 |
| First Use In Commerce Date | Tuesday, July 23, 2024 |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, February 1, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | Monday, November 30, 2020 |
| First Use In Commerce Date | Tuesday, July 23, 2024 |
| Party Name | LABORATORIOS HIPRA, S.A. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | AMER (GIRONA) 17170 ES |
| Party Name | LABORATORIOS HIPRA, S.A. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | AMER (GIRONA) 17170 ES |
| Event Date | Event Description |
| Thursday, February 24, 2022 | ASSIGNED TO LIE |
| Tuesday, February 1, 2022 | NEW APPLICATION ENTERED |
| Tuesday, February 1, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, February 18, 2022 | TEAS VOLUNTARY AMENDMENT RECEIVED |
| Thursday, February 24, 2022 | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED |
| Wednesday, November 9, 2022 | ASSIGNED TO EXAMINER |
| Wednesday, November 23, 2022 | NON-FINAL ACTION WRITTEN |
| Wednesday, November 23, 2022 | NON-FINAL ACTION E-MAILED |
| Wednesday, November 23, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, May 23, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, May 23, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, May 24, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, June 12, 2023 | FINAL REFUSAL WRITTEN |
| Monday, June 12, 2023 | FINAL REFUSAL E-MAILED |
| Monday, June 12, 2023 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Wednesday, September 6, 2023 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Wednesday, September 6, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, September 6, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, September 18, 2023 | EXAMINERS AMENDMENT -WRITTEN |
| Monday, September 18, 2023 | EXAMINERS AMENDMENT E-MAILED |
| Monday, September 18, 2023 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Monday, September 18, 2023 | EXAMINER'S AMENDMENT ENTERED |
| Monday, September 18, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, October 4, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, October 24, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, October 24, 2023 | PUBLISHED FOR OPPOSITION |
| Tuesday, December 19, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Thursday, June 20, 2024 | SOU TEAS EXTENSION RECEIVED |
| Thursday, December 19, 2024 | SOU TEAS EXTENSION RECEIVED |
| Thursday, June 20, 2024 | SOU EXTENSION 1 FILED |
| Thursday, June 20, 2024 | SOU EXTENSION 1 GRANTED |
| Thursday, June 20, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, December 19, 2024 | SOU EXTENSION 2 FILED |
| Thursday, December 19, 2024 | SOU EXTENSION 2 GRANTED |
| Wednesday, June 18, 2025 | USE AMENDMENT FILED |
| Friday, October 3, 2025 | STATEMENT OF USE PROCESSING COMPLETE |
| Wednesday, June 18, 2025 | TEAS STATEMENT OF USE RECEIVED |
| Monday, March 3, 2025 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |